Pethidine dose and female sex as risk factors for nausea after esophagogastroduodenoscopy

Toshihiro Nishizawa, Hidekazu Suzuki, Masahide Arita, Yosuke Kataoka, Kazushi Fukagawa, Daisuke Ohki, Keisuke Hata, Toshio Uraoka, Takanori Kanai, Naohisa Yahagi, Osamu Toyoshima

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Nausea and vomiting after esophagogastroduodenoscopy have not been studied in detail. The aim of this study was to evaluate the risk factors for post-endoscopic nausea. We performed a case-control study at the Toyoshima Endoscopy Clinic. Eighteen patients with post-endoscopic nausea and 190 controls without post-endoscopic nausea were analyzed. We conducted univariate and multivariate logistic regression analyses with respect to patient age; sex; body height; body weight; the use of psychotropic drugs as baseline medications; and the dosing amounts of midazolam, pethidine, flumazenil and naloxone. On univariate analysis, post-endoscopic nausea was significantly related with patient age (odds ratio = 0.946); female sex (odds ratio = 10.85); body weight (odds ratio = 0.975); and the dose per kg body weight of pethidine (odds ratio = 53.03), naloxone (odds ratio = 1.676), and flumazenil (odds ratio = 1.26). On multivariate analysis, the dose per kg body weight of pethidine (odds ratio = 21.67, p = 0.004) and female sex (odds ratio = 13.12, p = 0.047) were the factors independently associated with post-endoscopic nausea. The prevalence of nausea after esophagogastroduodenoscopy was 0.49% (18/3, 654). In conclusion, post-endoscopic nausea was associated with the dose of pethidine and female sex.

Original languageEnglish
Pages (from-to)230-232
Number of pages3
JournalJournal of Clinical Biochemistry and Nutrition
Volume63
Issue number3
DOIs
Publication statusPublished - 2018 Nov 1

Fingerprint

Digestive System Endoscopy
Meperidine
Nausea
Odds Ratio
Flumazenil
Naloxone
Body Weight
Endoscopy
Midazolam
Psychotropic Drugs
Sex Ratio
Logistics
Body Height
Vomiting
Case-Control Studies
Multivariate Analysis
Logistic Models
Regression Analysis

Keywords

  • Endoscopy
  • Nausea
  • Pethidine

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Clinical Biochemistry

Cite this

Nishizawa, T., Suzuki, H., Arita, M., Kataoka, Y., Fukagawa, K., Ohki, D., ... Toyoshima, O. (2018). Pethidine dose and female sex as risk factors for nausea after esophagogastroduodenoscopy. Journal of Clinical Biochemistry and Nutrition, 63(3), 230-232. https://doi.org/10.3164/jcbn.18-5

Pethidine dose and female sex as risk factors for nausea after esophagogastroduodenoscopy. / Nishizawa, Toshihiro; Suzuki, Hidekazu; Arita, Masahide; Kataoka, Yosuke; Fukagawa, Kazushi; Ohki, Daisuke; Hata, Keisuke; Uraoka, Toshio; Kanai, Takanori; Yahagi, Naohisa; Toyoshima, Osamu.

In: Journal of Clinical Biochemistry and Nutrition, Vol. 63, No. 3, 01.11.2018, p. 230-232.

Research output: Contribution to journalArticle

Nishizawa, T, Suzuki, H, Arita, M, Kataoka, Y, Fukagawa, K, Ohki, D, Hata, K, Uraoka, T, Kanai, T, Yahagi, N & Toyoshima, O 2018, 'Pethidine dose and female sex as risk factors for nausea after esophagogastroduodenoscopy', Journal of Clinical Biochemistry and Nutrition, vol. 63, no. 3, pp. 230-232. https://doi.org/10.3164/jcbn.18-5
Nishizawa, Toshihiro ; Suzuki, Hidekazu ; Arita, Masahide ; Kataoka, Yosuke ; Fukagawa, Kazushi ; Ohki, Daisuke ; Hata, Keisuke ; Uraoka, Toshio ; Kanai, Takanori ; Yahagi, Naohisa ; Toyoshima, Osamu. / Pethidine dose and female sex as risk factors for nausea after esophagogastroduodenoscopy. In: Journal of Clinical Biochemistry and Nutrition. 2018 ; Vol. 63, No. 3. pp. 230-232.
@article{413c6cbb233944fa919b0d8afcba3265,
title = "Pethidine dose and female sex as risk factors for nausea after esophagogastroduodenoscopy",
abstract = "Nausea and vomiting after esophagogastroduodenoscopy have not been studied in detail. The aim of this study was to evaluate the risk factors for post-endoscopic nausea. We performed a case-control study at the Toyoshima Endoscopy Clinic. Eighteen patients with post-endoscopic nausea and 190 controls without post-endoscopic nausea were analyzed. We conducted univariate and multivariate logistic regression analyses with respect to patient age; sex; body height; body weight; the use of psychotropic drugs as baseline medications; and the dosing amounts of midazolam, pethidine, flumazenil and naloxone. On univariate analysis, post-endoscopic nausea was significantly related with patient age (odds ratio = 0.946); female sex (odds ratio = 10.85); body weight (odds ratio = 0.975); and the dose per kg body weight of pethidine (odds ratio = 53.03), naloxone (odds ratio = 1.676), and flumazenil (odds ratio = 1.26). On multivariate analysis, the dose per kg body weight of pethidine (odds ratio = 21.67, p = 0.004) and female sex (odds ratio = 13.12, p = 0.047) were the factors independently associated with post-endoscopic nausea. The prevalence of nausea after esophagogastroduodenoscopy was 0.49{\%} (18/3, 654). In conclusion, post-endoscopic nausea was associated with the dose of pethidine and female sex.",
keywords = "Endoscopy, Nausea, Pethidine",
author = "Toshihiro Nishizawa and Hidekazu Suzuki and Masahide Arita and Yosuke Kataoka and Kazushi Fukagawa and Daisuke Ohki and Keisuke Hata and Toshio Uraoka and Takanori Kanai and Naohisa Yahagi and Osamu Toyoshima",
year = "2018",
month = "11",
day = "1",
doi = "10.3164/jcbn.18-5",
language = "English",
volume = "63",
pages = "230--232",
journal = "Journal of Clinical Biochemistry and Nutrition",
issn = "0912-0009",
publisher = "The Society for Free Radical Research Japan",
number = "3",

}

TY - JOUR

T1 - Pethidine dose and female sex as risk factors for nausea after esophagogastroduodenoscopy

AU - Nishizawa, Toshihiro

AU - Suzuki, Hidekazu

AU - Arita, Masahide

AU - Kataoka, Yosuke

AU - Fukagawa, Kazushi

AU - Ohki, Daisuke

AU - Hata, Keisuke

AU - Uraoka, Toshio

AU - Kanai, Takanori

AU - Yahagi, Naohisa

AU - Toyoshima, Osamu

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Nausea and vomiting after esophagogastroduodenoscopy have not been studied in detail. The aim of this study was to evaluate the risk factors for post-endoscopic nausea. We performed a case-control study at the Toyoshima Endoscopy Clinic. Eighteen patients with post-endoscopic nausea and 190 controls without post-endoscopic nausea were analyzed. We conducted univariate and multivariate logistic regression analyses with respect to patient age; sex; body height; body weight; the use of psychotropic drugs as baseline medications; and the dosing amounts of midazolam, pethidine, flumazenil and naloxone. On univariate analysis, post-endoscopic nausea was significantly related with patient age (odds ratio = 0.946); female sex (odds ratio = 10.85); body weight (odds ratio = 0.975); and the dose per kg body weight of pethidine (odds ratio = 53.03), naloxone (odds ratio = 1.676), and flumazenil (odds ratio = 1.26). On multivariate analysis, the dose per kg body weight of pethidine (odds ratio = 21.67, p = 0.004) and female sex (odds ratio = 13.12, p = 0.047) were the factors independently associated with post-endoscopic nausea. The prevalence of nausea after esophagogastroduodenoscopy was 0.49% (18/3, 654). In conclusion, post-endoscopic nausea was associated with the dose of pethidine and female sex.

AB - Nausea and vomiting after esophagogastroduodenoscopy have not been studied in detail. The aim of this study was to evaluate the risk factors for post-endoscopic nausea. We performed a case-control study at the Toyoshima Endoscopy Clinic. Eighteen patients with post-endoscopic nausea and 190 controls without post-endoscopic nausea were analyzed. We conducted univariate and multivariate logistic regression analyses with respect to patient age; sex; body height; body weight; the use of psychotropic drugs as baseline medications; and the dosing amounts of midazolam, pethidine, flumazenil and naloxone. On univariate analysis, post-endoscopic nausea was significantly related with patient age (odds ratio = 0.946); female sex (odds ratio = 10.85); body weight (odds ratio = 0.975); and the dose per kg body weight of pethidine (odds ratio = 53.03), naloxone (odds ratio = 1.676), and flumazenil (odds ratio = 1.26). On multivariate analysis, the dose per kg body weight of pethidine (odds ratio = 21.67, p = 0.004) and female sex (odds ratio = 13.12, p = 0.047) were the factors independently associated with post-endoscopic nausea. The prevalence of nausea after esophagogastroduodenoscopy was 0.49% (18/3, 654). In conclusion, post-endoscopic nausea was associated with the dose of pethidine and female sex.

KW - Endoscopy

KW - Nausea

KW - Pethidine

UR - http://www.scopus.com/inward/record.url?scp=85056143278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056143278&partnerID=8YFLogxK

U2 - 10.3164/jcbn.18-5

DO - 10.3164/jcbn.18-5

M3 - Article

AN - SCOPUS:85056143278

VL - 63

SP - 230

EP - 232

JO - Journal of Clinical Biochemistry and Nutrition

JF - Journal of Clinical Biochemistry and Nutrition

SN - 0912-0009

IS - 3

ER -